Preliminary Program (Nov 4-6, 2024) - CET/CEST (Cent Europe Summer, GMT+2)
Preliminary Program (Nov 4-6, 2024) - CET/CEST (Cent Europe Summer, GMT+2)
Insights from world-leading scientist and serial Entrepreneur. What does the next 30 years look like?
Explore strategies for investing in a sustainable future with global pharma leaders. This session will delve into innovative approaches and best practices that drive long-term growth while addressing environmental and social responsibilities. Join us to learn how the pharma industry is shaping a healthier and more sustainable future.
- Magnus Björsne - Executive Director AZ BioVenture Innovation Unit, CEO AZ BioVentureHub AB, AstraZeneca
In this scene setter session, join leading industry advisors IQVIA and Citeline as they discuss Biopharma key challenges facing decision makers in research-driven biopharma companies. From R&D through to market access and launch excellence in key disease areas such as rare diseases, the conversation will touch on the fast-changing dynamics across the entire biopharmaceutical value chain. This data-driven fireside chat, filled with relevant case studies, is highly educational and sets the scene for the in-depth panel discussions that will follow throughout BIO-Europe.
Industry leaders will share insights on emerging trends, collaborative approaches, and key considerations shaping the future of partnering and M&A activities, fostering strategic synergies for mutual growth and innovation.
Through the looking glass, this series of fireside chats will showcase the “Greats” from across the decades and spotlight headline M&A and partnering deals done over the past 30 years.
Gain insights from leading pharma and venture investors on navigating the dealmaking landscape and standing out in the current climate. Discover strategies, trends, and key considerations for successful partnerships. Join this session to learn how to thrive in today's competitive environment and drive impactful collaborations.
- Shaun Grady - Senior VP, Business Development Operations, AstraZeneca
Delve into the minds of seasoned investors as they dissect the current investment landscape and forecast future trajectories. Gain valuable insights into emerging trends, risk assessments, and strategic maneuvers shaping the future of investment in the ever-evolving market landscape.
Discover insights, strategies, and collaborative approaches to bridge the divide between research and commercialization. Learn from industry leaders as they share experiences and best practices to navigate this critical phase and drive innovation forward.
- Peter Heinrich - Co-founder, Managing Director, Sinfonie LSM
- Ayokunmi Ajetunmobi - Director of Venture Development, Pioneer Group
Join us for A Media Round-up' as we dive into a comprehensive recap of BIO-Europe 2024. Get a pulse on the event with highlights, fresh perspectives, key insights, and impactful takeaways from speakers and participants. Gear up for BIO-Europe 2025 as we welcome you to…!"
- Explore the latest trends in partnering and M&A activities, discovering strategic opportunities for growth and innovation.
Hear from industry leaders as we navigate the evolving landscape together, unlocking the potential of tomorrow's breakthroughs.
Featuring four of the hottest modalities emerging, offering insights into their potential to revolutionize the therapeutic landscape.
As the pharma patent cliff approaches, this panel will explore its impact on the industry, examining future pipelines and emerging partnering opportunities. Join industry leaders to discuss strategies for innovation and collaboration, ensuring sustained growth and advancement in the lifescience landscape. Discover what lies ahead in this pivotal decade.
With the land grab by big pharma, how do companies identify the next generation ADC technologies?
Delve into the groundbreaking potential of cell and gene therapy and it’s potential to reshape healthcare as we know it. Explore the transformative impact of these therapies on disease treatment and prevention, challenging conventional medical paradigms. Discover how these innovative modalities are rewriting the rules of healthcare for a brighter future.
This session delves into the buzz surrounding GLP-1 modalities, shedding light on the transformative potential and future prospects for this groundbreaking class of treatments.
Uncover AI's profound impact on drug discovery, clinical trials, and personalized medicine, reshaping the industry's future. Join us as we navigate the evolving AI landscape, charting a course for innovation and advancement in biopharma and beyond.
BioProcess Insider (a BioProcess International publication) editorial team sits down with a select panel of experts to reflect on how the quarterly movements of the wider pharma industry are affecting the bio services space. We look at how global events, deal making, and regulatory and tech advancements are determining the factors driving or squeezing production, while also finding time to focus on developments within a key area of the industry.
Explore why AI is not just a trend but a transformative force shaping the future of healthcare and biopharma. Gain insights into its profound implications for research, development, and patient care.
Hear how AI algorithms are reshaping the landscape, accelerating the identification and development of novel therapeutics. Learn from industry experts about the latest advancements, challenges, and promising opportunities in this frontier of innovation.
Explore how AI-driven technologies are revolutionizing medical diagnostics, enhancing accuracy, efficiency, and patient outcomes. Gain valuable insights from experts on the latest developments, challenges, and future prospects in leveraging AI for diagnostic purposes.
Explore the transformative impact of evolving pharmaceutical legislation on investor and company strategies within the life science ecosystem. Delve into the intricate interplay between regulatory changes, market dynamics, and strategic decision-making, as industry experts navigate the path forward amidst shifting landscapes and emerging opportunities.
Join us for a fireside chat where experts assess the impact of US policies on the European life sciences ecosystem. Delve into the regulatory landscape, market dynamics, and strategic implications, exploring how transatlantic influences shape the future of biopharma innovation and collaboration.